Side effects that seemed challenging at week 9 have typically faded by week 17
Subsequent work by Pickart and Margolina identified clusters of affected genes spanning DNA repair, antioxidant defense, ubiquitinproteasome activity, anti-inflammatory signaling, and tissue remodeling [2]
Chemotherapy activates the DDR pathway
Users under 150 lbs may experience stronger side effects at standard doses, particularly with GLP-1 agonists
This inflammatory state not only damages surrounding healthy cells but can also lead to excessive activation of the immune system, further exacerbating tissue damage (Byrns China et al., 2024
GHK-Cu Observations in Wound and Skin Models Experimental wound models, including those involving diabetic conditions, propose that GHK-Cu may support more rapid tissue closure and oxidative stress responses